CA3211812A1 - Composition liquide pour inhalation pour cigarettes electroniques - Google Patents
Composition liquide pour inhalation pour cigarettes electroniques Download PDFInfo
- Publication number
- CA3211812A1 CA3211812A1 CA3211812A CA3211812A CA3211812A1 CA 3211812 A1 CA3211812 A1 CA 3211812A1 CA 3211812 A CA3211812 A CA 3211812A CA 3211812 A CA3211812 A CA 3211812A CA 3211812 A1 CA3211812 A1 CA 3211812A1
- Authority
- CA
- Canada
- Prior art keywords
- weight
- composition
- nicotine
- cigarette
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 239000003571 electronic cigarette Substances 0.000 title claims abstract description 34
- 239000007788 liquid Substances 0.000 title abstract description 12
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims abstract description 40
- 229960002715 nicotine Drugs 0.000 claims abstract description 39
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims abstract description 39
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims abstract description 10
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims abstract description 10
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 8
- 239000003755 preservative agent Substances 0.000 claims abstract description 8
- 230000002335 preservative effect Effects 0.000 claims abstract description 8
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 21
- 241000208125 Nicotiana Species 0.000 claims description 6
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 239000004299 sodium benzoate Substances 0.000 claims description 4
- 235000019568 aromas Nutrition 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical group [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims description 2
- 229940097362 cyclodextrins Drugs 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 235000019504 cigarettes Nutrition 0.000 description 24
- 239000002245 particle Substances 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 8
- 231100000419 toxicity Toxicity 0.000 description 7
- 230000001988 toxicity Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 239000000443 aerosol Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000000391 smoking effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000002485 combustion reaction Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000008447 perception Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 2
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 150000004005 nitrosamines Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/301—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
- A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
- A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
Abstract
La présente invention concerne une composition liquide pour inhalation pour cigarettes électroniques. En particulier, la présente invention concerne une composition pour inhalation par cigarette électronique comprenant les composants suivants : a) de 25 à 40 % en poids d'eau, b) de 30 à 50 % en poids de 1,3-propanediol, c) de 20 à 30 % en poids de glycérol d) de 0,1 à 5 % en poids d'un conservateur, e) facultativement, de 0,2 à 6 % en poids de nicotine, f) facultativement, de 0 à 10 % en poids d'un aromatisant, g) facultativement, de 0,1 à 5 % en poids d'au moins une cyclodextrine.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102021000005027A IT202100005027A1 (it) | 2021-03-04 | 2021-03-04 | Composizione liquida da inalazione per sigarette elettroniche |
| IT102021000005027 | 2021-03-04 | ||
| PCT/IB2021/062189 WO2022185117A1 (fr) | 2021-03-04 | 2021-12-22 | Composition liquide pour inhalation pour cigarettes électroniques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3211812A1 true CA3211812A1 (fr) | 2022-09-09 |
Family
ID=75850578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3211812A Pending CA3211812A1 (fr) | 2021-03-04 | 2021-12-22 | Composition liquide pour inhalation pour cigarettes electroniques |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240148046A1 (fr) |
| EP (1) | EP4301165A1 (fr) |
| JP (1) | JP2024508528A (fr) |
| KR (1) | KR20230154446A (fr) |
| CN (1) | CN117156984A (fr) |
| AU (1) | AU2021431664A1 (fr) |
| CA (1) | CA3211812A1 (fr) |
| IT (1) | IT202100005027A1 (fr) |
| WO (1) | WO2022185117A1 (fr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201817859D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
| CN114007449B (zh) * | 2019-06-05 | 2023-09-12 | 菲利普莫里斯生产公司 | 尼古丁组合物、制备方法和包含所述尼古丁组合物的气溶胶生成制品 |
| HUE062528T2 (hu) * | 2019-06-05 | 2023-11-28 | Philip Morris Products Sa | Folyékony dohánykivonat, készítési eljárás és ilyet magában foglaló aeroszolfejlesztõ termék |
-
2021
- 2021-03-04 IT IT102021000005027A patent/IT202100005027A1/it unknown
- 2021-12-22 EP EP21830520.9A patent/EP4301165A1/fr active Pending
- 2021-12-22 CN CN202180095093.9A patent/CN117156984A/zh active Pending
- 2021-12-22 US US18/548,533 patent/US20240148046A1/en active Pending
- 2021-12-22 CA CA3211812A patent/CA3211812A1/fr active Pending
- 2021-12-22 KR KR1020237033352A patent/KR20230154446A/ko unknown
- 2021-12-22 JP JP2023553487A patent/JP2024508528A/ja active Pending
- 2021-12-22 AU AU2021431664A patent/AU2021431664A1/en active Pending
- 2021-12-22 WO PCT/IB2021/062189 patent/WO2022185117A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230154446A (ko) | 2023-11-08 |
| CN117156984A (zh) | 2023-12-01 |
| US20240148046A1 (en) | 2024-05-09 |
| JP2024508528A (ja) | 2024-02-27 |
| WO2022185117A1 (fr) | 2022-09-09 |
| AU2021431664A1 (en) | 2023-09-14 |
| IT202100005027A1 (it) | 2022-09-04 |
| EP4301165A1 (fr) | 2024-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6470894B2 (en) | Glutathione, green tea, grape seed extract to neutralize tobacco free radicals | |
| ES2831124T3 (es) | Solución que comprende nicotina en forma no protonada y en forma protonada | |
| KR101208473B1 (ko) | 전자 담배용 무화용액 조성물 | |
| AU743757B2 (en) | Smoking products containing antioxidants | |
| US4917120A (en) | Nicotine impact modification | |
| US20040255965A1 (en) | Reconstituted tobaccos containing additive materials | |
| US6415798B1 (en) | Antioxidants to neutralize tobacco free radicals | |
| US5016655A (en) | Cigarette manufacturing process | |
| EP2265263A2 (fr) | Composition à mâcher et utilisation | |
| US20070068542A1 (en) | Seven different-flavored cigarette substitute | |
| CN112674345A (zh) | 一种环糊精添加剂及其制备方法和应用 | |
| JP7457069B2 (ja) | 組成物 | |
| KR20210115609A (ko) | 클로브 부산물이 함유된 판상엽 시트 및 이를 포함하는 흡연물품 | |
| KR101257828B1 (ko) | 다마스콘 함유 금연보조제 조성물 | |
| WO2007083196A2 (fr) | Incorporation de composes de liberation d'ammoniac dans des articles de tabac | |
| US20050263165A1 (en) | Tobacco leaf substitute | |
| CA3211812A1 (fr) | Composition liquide pour inhalation pour cigarettes electroniques | |
| US20040094170A1 (en) | Nicotine free cigarette substitute | |
| JP2023538838A (ja) | 燃焼抑制材料及びその使用 | |
| RU2745353C1 (ru) | Ароматизированная испаряемая композиция | |
| Alshareef et al. | Toxicology of Commonly Found Ingredients in E-Cigarettes: A Brief Review | |
| US20030131857A1 (en) | Nicotine free cigarette substitute | |
| JP7102590B1 (ja) | 電子タバコ用リキッド、および電子タバコ用リキッドの製造方法、ならびに電子タバコ用カートリッジ、電子タバコ | |
| JP7260104B2 (ja) | 低発火性のタバコ用巻紙のコーティング組成物、これを利用した喫煙物品および低発火性のタバコ用巻紙の製造方法 | |
| WO2024105406A1 (fr) | Consommable pour formulation aérosolisable |